🇺🇸 FDA
Patent

US 7541381

Non-covalent inhibitors of AmpC β-lactamase

granted A61KA61K31/18A61K31/44

Quick answer

US patent 7541381 (Non-covalent inhibitors of AmpC β-lactamase) held by Northwestern University expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/18, A61K31/44, A61K31/4965, A61P